Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent's has enrolled the first patient in the VITAL-EP study. The study is ...

Background. The prognostic significance of a second programmed ventricular stimulation (PVS) at electrophysiology study (EPS), when the first PVS is negative for inducible ventricular tachycardia (VT) ...

Healio and Cardiology Today present the most-read articles on arrhythmia disorders published in 2019. In no particular order, Healio readers were most interested in results of the Apple Heart Study, ...

SAN FRANCISCO--(BUSINESS WIRE)--Vektor Medical today announced positive results from its “Vektor vMap™ Clinical Validation Study” evaluating the accuracy of cardiac mapping with vMap™. The study ...

Members of CVRI Theme ‘Arrhythmias & Channelopathies’ are involved in various translational and clinical research projects in cardiac electrophysiology. Specific areas of interest include the genetics ...

Titled “Role of Cardiac Clock Misalignment in Promoting Arrhythmias in Swine and Donor Human Hearts,” the five-year, $3.4 million study is funded by a R01 grant from the National Heart, Lung and Blood ...

First Patient Enrolled at Ascension St. Vincent’s in Jacksonville, Florida Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced that Ascension St. Vincent ...